Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medtronic plc Director's Dealing 2019

Jun 7, 2019

29841_dirs_2019-06-07_f586ce07-12c1-442c-9a5e-680193241611.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2019-06-06

Reporting Person: Martha Geoffrey (EVP & GroupPres Restora Therap)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-06-06 Ordinary Shares S 11000 $96.053 Disposed 48918 Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $95.75 to $96.45, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2: This balance increased by 716 shares due to exempt transactions such as dividend reinvestment.